{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T07:25:30Z","timestamp":1767165930723,"version":"build-2238731810"},"reference-count":22,"publisher":"Wiley","license":[{"start":{"date-parts":[[2022,8,16]],"date-time":"2022-08-16T00:00:00Z","timestamp":1660608000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017959","name":"Health Commission of Hebei Province","doi-asserted-by":"publisher","award":["20211787"],"award-info":[{"award-number":["20211787"]}],"id":[{"id":"10.13039\/100017959","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Evidence-Based Complementary and Alternative Medicine"],"published-print":{"date-parts":[[2022,8,16]]},"abstract":"\n Objective. To determine the influence of Entresto on clinical symptoms, ventricular remodeling (VR), and economic stress of patients with both acute myocardial infarction (AMI) and acute heart failure (AHF). Methods. Totally 120 patients with AMI complicated with AHF admitted to our hospital between January 2017 and August 2019 were enrolled and randomly assigned to an observation group (obs group) and a control group (con group) (each n\u2009=\u200960). The obs group was treated with Entresto, while the other with angiotensin-converting enzyme inhibitors (ACEI). After treatment, the efficacy on both groups was evaluated, and their cardiac function-associated indexes (left ventricular end-systolic diameter (LVESd), left ventricular end-diastolic dimension (LVEDd), left ventricular ejection fraction (LVEF), VR-associated indexes (interventricular septal thickness (IVST), and left ventricular mass index (LVMI)) were determined and compared before treatment and after 1\u2009month of treatment. Additionally, their NT-pro-BNP, CRP, and TNF-\u03b1 were tested and compared before and after treatment, and they were also compared in hospitalization time, treatment expense, readmission rate within one year after discharge, and adverse events. Results. After treatment, the obs group showed notably higher efficacy than the con group (\n \n \n P<\/a:mi>\n <<\/a:mo>\n 0.05<\/a:mn>\n <\/a:math>\n <\/jats:inline-formula>\n ). Before treatment, the two groups were not greatly different in LVESd, LVEDd, LVEF, IVST, LVMI, NT-pro BNP, CRP, and TNF-\u03b1 (all\n \n \n P<\/c:mi>\n ><\/c:mo>\n 0.05<\/c:mn>\n <\/c:math>\n <\/jats:inline-formula>\n ), while after treatment, these indexes of both groups were improved, but the improvement in the obs group was more notable (\n \n \n P<\/e:mi>\n <<\/e:mo>\n 0.05<\/e:mn>\n <\/e:math>\n <\/jats:inline-formula>\n ). Additionally, the hospitalization time, treatment expense, readmission rate one year after discharge, and incidence of adverse events in the obs group were notably lower (all\n \n \n P<\/g:mi>\n <<\/g:mo>\n 0.05<\/g:mn>\n <\/g:math>\n <\/jats:inline-formula>\n ). Conclusion. For patients with both AMI and AHF, Entresto can contribute to strong amelioration of their clinical symptoms and prognosis and ventricular reverse-remodeling, with a high safety, so it is worthy of clinical promotion.\n <\/jats:p>","DOI":"10.1155\/2022\/7650937","type":"journal-article","created":{"date-parts":[[2022,8,16]],"date-time":"2022-08-16T18:50:07Z","timestamp":1660675807000},"page":"1-7","source":"Crossref","is-referenced-by-count":4,"title":["Effect of Entresto on Clinical Symptoms, Ventricular Remodeling, Rehabilitation, and Hospitalization Rate in Patients with Both Acute Myocardial Infarction and Acute Heart Failure"],"prefix":"10.1155","volume":"2022","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3278-5829","authenticated-orcid":true,"given":"Guiping","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Cardiology, Tangshan Gongren Hospital, Tangshan, Hebei 063000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7248-0758","authenticated-orcid":true,"given":"Xiaokun","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tangshan Gongren Hospital, Tangshan, Hebei 063000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8508-2695","authenticated-orcid":true,"given":"Zimo","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tangshan Gongren Hospital, Tangshan, Hebei 063000, China"},{"name":"Department of Cardiology, Tangshan Gongren Hospital, North China University of Science and Technology, Tangshan, Hebei 063000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6726-4789","authenticated-orcid":true,"given":"Juanjuan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tangshan Gongren Hospital, Tangshan, Hebei 063000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9594-2364","authenticated-orcid":true,"given":"Shuping","family":"Zuo","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tangshan Gongren Hospital, Tangshan, Hebei 063000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4801-7170","authenticated-orcid":true,"given":"Suya","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tangshan Gongren Hospital, Tangshan, Hebei 063000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6096-398X","authenticated-orcid":true,"given":"Yanan","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tangshan Gongren Hospital, Tangshan, Hebei 063000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0974-7149","authenticated-orcid":true,"given":"Qi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tangshan Gongren Hospital, Tangshan, Hebei 063000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccl.2020.01.008"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.1493"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1016\/j.hfc.2016.03.001"},{"key":"4","article-title":"Adherence to beta-blockers and long-term risk of heart failure and mortality after a myocardial infarction","volume":"8","author":"L. Desta","year":"2020","journal-title":"ESC Heart Failure"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.1670"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.7429\/pi.2019.721050"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.21201"},{"key":"8","doi-asserted-by":"publisher","DOI":"10.1016\/j.hfc.2020.06.004"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-018-0808-2"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jjcc.2020.10.011"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.12200"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000020636"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1161\/circheartfailure.119.006414"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(20)31824-9"},{"issue":"3","key":"15","first-page":"456","article-title":"Age-related sarcopenia as the risk factor of development of myocardial dysfunction and chronic heart failure in elderly patients with arterial hypertension","volume":"25","author":"N. V. Medvedev","year":"2012","journal-title":"Advances in Gerontology"},{"key":"16","doi-asserted-by":"publisher","DOI":"10.3109\/10715762.2013.845294"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.5603\/cj.a2020.0165"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-014-9442-y"},{"key":"19","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.117.029882"},{"key":"20","doi-asserted-by":"publisher","DOI":"10.1111\/jvim.15246"},{"key":"21","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.6.3865"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.129979"}],"updated-by":[{"DOI":"10.1155\/2023\/9823069","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T00:00:00Z","timestamp":1687305600000},"record-id":"45968"},{"DOI":"10.1155\/2023\/9823069","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T00:00:00Z","timestamp":1687305600000}}],"container-title":["Evidence-Based Complementary and Alternative Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/downloads.hindawi.com\/journals\/ecam\/2022\/7650937.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/ecam\/2022\/7650937.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/ecam\/2022\/7650937.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,16]],"date-time":"2022-08-16T18:50:12Z","timestamp":1660675812000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.hindawi.com\/journals\/ecam\/2022\/7650937\/"}},"subtitle":[],"editor":[{"given":"Tian jiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2022,8,16]]},"references-count":22,"alternative-id":["7650937","7650937"],"URL":"https:\/\/doi.org\/10.1155\/2022\/7650937","relation":{},"ISSN":["1741-4288","1741-427X"],"issn-type":[{"value":"1741-4288","type":"electronic"},{"value":"1741-427X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8,16]]}}}